Skip to content
Simpler Grants

No. HT942526OCRPCTA · Defense Health Agency Contracting Activity - DHACA

Open

DoW Ovarian Cancer, Clinical Trial Award

grants.gov listing Full announcement (NOFO)
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“full application submission is by invitation only.” — From the announcement
Award range
Not specified
Expected awards
~2
Application deadline
Oct 1, 2026 29 days left
Posted
May 4, 2026
Last verified
4 days ago

At a glance

AI summary

The Ovarian Cancer Research Program includes awards for clinical trials, investigator-initiated research, early-career academy awards, and pilot research. Eligible applicants range from postdoctoral or clinical fellows to assistant professors and independent investigators at academic levels, depending on the mechanism; some awards require a mentor and some are limited to early-career investigators within 5 or 12 years of their last postdoctoral or clinical fellowship. Funding ranges from $350,000 total costs for 2 years for the Pilot Award to up to $2.8 million total costs for 4 years for the Clinical Trial Award, with other mechanisms capped between $1.05 million and $1.4 million over 4 years. Some awards require preliminary data, some do not allow clinical trials, and several require a letter of intent or preproposal before the full application. The announcement does not state any geographic restriction or cost-share requirement.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097 — —
FY 2023 1,115 — —
FY 2022 1,186 — —
FY 2021 1,023 — —

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026